Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to $86.1 million.

  • P3 Health Partners' Depreciation & Amortization (CF) fell 295.3% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.3 million, marking a year-over-year decrease of 256.3%. This contributed to the annual value of $86.1 million for FY2024, which is 71.19% down from last year.
  • According to the latest figures from FY2024, P3 Health Partners' Depreciation & Amortization (CF) is $86.1 million, which was down 71.19% from $86.7 million recorded in FY2023.
  • P3 Health Partners' 5-year Depreciation & Amortization (CF) high stood at $87.3 million for FY2022, and its period low was $795172.0 during FY2020.
  • Over the past 5 years, P3 Health Partners' median Depreciation & Amortization (CF) value was $86.1 million (recorded in 2024), while the average stood at $52.5 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 9920.29% in 2020, then crashed by 71.19% in 2024.
  • P3 Health Partners' Depreciation & Amortization (CF) (Annual) stood at $795172.0 in 2020, then soared by 98.07% to $1.6 million in 2021, then surged by 5442.16% to $87.3 million in 2022, then decreased by 0.7% to $86.7 million in 2023, then dropped by 0.71% to $86.1 million in 2024.
  • Its last three reported values are $86.1 million in FY2024, $86.7 million for FY2023, and $87.3 million during FY2022.